{"id":"NCT01255423","sponsor":"Novartis","briefTitle":"Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied 4 Times Daily in Subjects With Acute Ankle Sprain","officialTitle":"A Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel (DSG) 1% Applied 4 Times Daily in Subjects With Acute Ankle Sprain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-11","primaryCompletion":"2011-06","completion":"2011-06","firstPosted":"2010-12-07","resultsPosted":"2012-10-04","lastUpdate":"2012-10-04"},"enrollment":206,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Ankle Sprain"],"interventions":[{"type":"DRUG","name":"Diclofenac sodium topical gel 1%","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Diclofenac sodium topical gel 1%","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy of Diclofenac Sodium Topical (DSG) 1% compared with placebo applied four times a day in subjects with acute ankle sprains under 'in-use' conditions, in particular with regard to pain relief.","primaryOutcome":{"measure":"Pain on Movement","timeFrame":"72 hours","effectByArm":[{"arm":"Diclofenac Sodium Topical Gel 1%","deltaMin":37.4,"sd":25.2},{"arm":"Placebo","deltaMin":38.8,"sd":24.1}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":9,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":104},"commonTop":["Nervous Sytem disorders","Musculoskeletal and connective tissue disorder","Skin and subcutaneous tissue disorders","Infection and infestations","General disorders and administration site conditions"]}}